Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 9 hours ago
Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
about 9 hours ago
On some level, Eli Lilly’s partnership with computing giant Nvidia feels inevitable...
How physiology powers biotech innovation
about 10 hours ago
From AI to wearables, physiology turns data into discovery and drives smarter...
Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates
about 11 hours ago
A new biotech has risen from the ashes of Novartis’ red-hot $12...
FDA slams ExThera with warning letter over controversial blood filter device
about 14 hours ago
The FDA slammed ExThera with a warning letter for deviating from the...
Chutes & Ladders—Sarepta CEO to step down as DM1 hits close to home
about 14 hours ago
A “fairly shocking and certainly ironic twist of fate” is ending Sarepta...
Earendil pens $885M pact to use WuXi XDC’s linker tech for next-gen ADCs
about 17 hours ago
AI research biotech Earendil Labs has penned a $885 million deal to...
Thermo Fisher unveils test to aid in dosing of antirejection drug
about 17 hours ago
Thermo Fisher Scientific is launching a new test it says can help...
Generate scores largest biotech IPO since 2024 with $400M Nasdaq listing
about 18 hours ago
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from...
Spatial Biomarker Panels for Clinical Trials
1 day ago
This webinar covers how recent advances in multiplex immunofluorescence technology are enabling...
‘Like talking to a brick wall’: Senate hearing takes aim at FDA’s rare disease review process
1 day ago
A panel of physicians, biotech leaders and patient advocates took aim at...
As CAR-T cell therapy gains ground on solid tumors, regulatory red tape hinders progress
1 day ago
A new highly sensitive cell therapy was able to wipe out three...
Analysts see potential in MDMA drug after AtaiBeckley reports improvements in anxiety trial
1 day ago
The trial was the first to assess R-MDMA in patients with social...